JP2025513462A5 - - Google Patents

Info

Publication number
JP2025513462A5
JP2025513462A5 JP2024562090A JP2024562090A JP2025513462A5 JP 2025513462 A5 JP2025513462 A5 JP 2025513462A5 JP 2024562090 A JP2024562090 A JP 2024562090A JP 2024562090 A JP2024562090 A JP 2024562090A JP 2025513462 A5 JP2025513462 A5 JP 2025513462A5
Authority
JP
Japan
Prior art keywords
alkyl
independently selected
pharmaceutically acceptable
prodrug
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024562090A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513462A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2023/050523 external-priority patent/WO2023201423A1/en
Publication of JP2025513462A publication Critical patent/JP2025513462A/ja
Publication of JP2025513462A5 publication Critical patent/JP2025513462A5/ja
Pending legal-status Critical Current

Links

JP2024562090A 2022-04-19 2023-04-18 セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体 Pending JP2025513462A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263332450P 2022-04-19 2022-04-19
US63/332,450 2022-04-19
PCT/CA2023/050523 WO2023201423A1 (en) 2022-04-19 2023-04-18 Indoline derivatives as serotonergic agents useful for the treatment of disorders related thereto

Publications (2)

Publication Number Publication Date
JP2025513462A JP2025513462A (ja) 2025-04-24
JP2025513462A5 true JP2025513462A5 (enExample) 2026-04-23

Family

ID=88418733

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024562090A Pending JP2025513462A (ja) 2022-04-19 2023-04-18 セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体
JP2024562088A Pending JP2025513461A (ja) 2022-04-19 2023-04-18 セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024562088A Pending JP2025513461A (ja) 2022-04-19 2023-04-18 セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体

Country Status (10)

Country Link
US (2) US20260083703A1 (enExample)
EP (2) EP4511360A4 (enExample)
JP (2) JP2025513462A (enExample)
KR (2) KR20250036719A (enExample)
CN (2) CN119546591A (enExample)
AU (2) AU2023258059A1 (enExample)
CA (2) CA3248179A1 (enExample)
IL (2) IL316401A (enExample)
MX (2) MX2024012864A (enExample)
WO (2) WO2023201423A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024044847A1 (en) * 2022-08-29 2024-03-07 Mindset Pharma Inc. Indoline derivatives as serotonergic agents useful for the treatment of disorders related thereto
WO2025104491A1 (en) * 2023-11-14 2025-05-22 Mindset Pharma Inc. Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto
WO2025123137A1 (en) * 2023-12-15 2025-06-19 10763942 Canada Inc. (Dba. Purminds Neuropharma) Heterocyclic compounds and methods of preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737725B1 (fr) * 1995-08-08 1997-10-31 Valentonine Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament
WO1998023587A1 (en) * 1996-11-26 1998-06-04 Allelix Biopharmaceuticals Inc. 5-cyclo indole compounds as 5-ht1d receptor ligands
KR100545329B1 (ko) * 1997-07-25 2006-01-24 하. 룬트벡 아크티에 셀스카브 인돌 및 2,3-디히드로인돌 유도체, 그들의 제조방법 및 사용
GB9819033D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds VI
AU1937300A (en) * 1998-12-11 2000-06-26 Eli Lilly And Company Indole derivatives and their use as 5-HT1F agonists
WO2003102097A1 (en) * 2002-05-31 2003-12-11 H. Lundbeck A/S The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole
WO2005084664A1 (ja) * 2004-03-08 2005-09-15 Kanazawa University Technology Licensing Organization Ltd. インドール誘導体及びその用途
JP5452223B2 (ja) * 2006-07-24 2014-03-26 テトラロジック ファーマシューティカルズ コーポレーション Ｉａｐ阻害剤
BR112022015379A2 (pt) * 2020-02-04 2022-09-27 Mindset Pharma Inc Derivados de 3-pirrolidino-indol como agentes psicodélicos serotonérgicos para o tratamento de distúrbios do snc

Similar Documents

Publication Publication Date Title
JP2025513462A5 (enExample)
JP2025513461A5 (enExample)
JP2023513679A5 (enExample)
IL295371A (en) Psilocyin derivatives as serotonergic psychedelics for the treatment of central nervous system disorders
JP7607732B2 (ja) 置換ピロロピリミジンｊａｋ阻害剤ならびにこれを作製および使用する方法
JP2024508922A5 (enExample)
ES2935476T3 (es) Esteroides neuroactivos, composiciones y usos de los mismos
JP2019520416A5 (enExample)
JP2023553094A5 (enExample)
JP2023512821A5 (enExample)
IL316401A (en) Indoline derivatives as estrogenic agents for the treatment of disorders
JP2024508545A5 (enExample)
JP2018505898A5 (enExample)
RU2009103307A (ru) ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ
AU2017207991A1 (en) Pyridazine derivatives as EAAT2 activators
JP6046149B2 (ja) Ｈ３受容体阻害剤としてのピペリジン及びピペラジン環を含むカルバメート／尿素誘導体
JP2022536773A5 (enExample)
JP7794910B2 (ja) Ｅａａｔ２活性化因子およびその使用方法
JP2020517607A5 (enExample)
JP2024517498A5 (enExample)
ES3057235T3 (en) Isoxazolidines as ripk1 inhibitors and use thereof
JPWO2010150840A1 (ja) Ｎ−置換−環状アミノ誘導体
ES2548683T3 (es) Amidas del ácido 4-(5-isoxazolil o 5-pirrazolil-1,2,4-oxadiazol-3-il)-mandélico como agonistas de receptor de esfingosina-1-fosfato 1
JP2024534572A5 (enExample)
JP2008508251A5 (enExample)